HAEMONETICS CORP/MASS
HAENYSE🏆 #1190 by market capEarnings Nov 4US Equity
$119.85▲ $1.62 (+1.37%)
Latest quoteTrack HAE
Get earnings, price moves & breaking news on Telegram
24h▲ 1.4%
7d▲ 3.2%
14d▼ 1.4%
30d▲ 13.2%
ytd▲ 49.6%
1y▲ 142.5%
🏦Market Cap
$5.45B
Small Cap
📈Revenue Growth (YoY)
0.4%
Slowing
📊Gross Margin
59.1%
Healthy
💵FCF Margin
18.1%
Healthy
⚖️P/S Ratio
4.0x
Fair
Otter Score
76
Strong
HAEMONETICS CORP/MASS
HAEAnalyst Ratings
Price
$119.85
Total
21
Raised
4
Lowered
4
Avg PT
$130.80
H / L
$140 / $119
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barrington Research | Reiterated | Outperform | 2026-10-09 | — | — |
Mizuho | Reiterated | Outperform | 2026-10-09 | — | — |
BTIG | Reiterated | Buy | 2026-10-08 | $130.00 | +8.50% |
Citigroup | Upgraded | Neutral → Buy | 2026-09-17 | — | — |
Raymond James | Reiterated | Outperform | 2026-09-03 | $125.00 | +4.30% |
Baird | Reiterated | Outperform | 2026-08-21 | — | — |
JP Morgan | Reiterated | Neutral | 2026-08-07 | — | — |
B of A Securities | Upgraded | Neutral → Buy | 2026-05-22 | — | — |
Needham | Downgraded | Buy → Hold | 2025-12-15 | $68.00 | −43.30% |
JMP Securities | Reiterated | Market Outperform | 2025-05-20 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2023-05-12 | — | — |
CJS Securities | Upgraded | Market Perform → Outperform | 2021-05-14 | — | — |
Jefferies | Reiterated | Buy | 2021-05-14 | — | — |
Sidoti & Co. | Downgraded | Buy → Neutral | 2016-08-15 | — | — |
Goldman Sachs | Upgraded | Sell → Neutral | 2016-05-16 | — | — |
BTIG Research | Reiterated | Neutral | 2015-12-14 | — | — |
Benchmark | Reiterated | Hold | 2015-04-27 | — | — |
William Blair | Downgraded | Outperform → Market Perform | 2014-03-24 | — | — |
Craig-Hallum | Downgraded | Buy → Hold | 2013-07-30 | — | — |
Alere Financial | Reiterated | Buy | 2013-07-26 | — | — |
Janney Capital | Reiterated | Buy | 2013-06-10 | — | — |
Institution
Barrington Research
Reiterated · Outperform · 2026-10-09
—
—
Mizuho
Reiterated · Outperform · 2026-10-09
—
—
BTIG
Reiterated · Buy · 2026-10-08
$130.00
+8.50%
Citigroup
Upgraded · Neutral → Buy · 2026-09-17
—
—
Raymond James
Reiterated · Outperform · 2026-09-03
$125.00
+4.30%
Baird
Reiterated · Outperform · 2026-08-21
—
—
JP Morgan
Reiterated · Neutral · 2026-08-07
—
—
B of A Securities
Upgraded · Neutral → Buy · 2026-05-22
—
—
Needham
Downgraded · Buy → Hold · 2025-12-15
$68.00
−43.30%
JMP Securities
Reiterated · Market Outperform · 2025-05-20
—
—
Morgan Stanley
Reiterated · Equal Weight · 2023-05-12
—
—
CJS Securities
Upgraded · Market Perform → Outperform · 2021-05-14
—
—
Jefferies
Reiterated · Buy · 2021-05-14
—
—
Sidoti & Co.
Downgraded · Buy → Neutral · 2016-08-15
—
—
Goldman Sachs
Upgraded · Sell → Neutral · 2016-05-16
—
—
BTIG Research
Reiterated · Neutral · 2015-12-14
—
—
Benchmark
Reiterated · Hold · 2015-04-27
—
—
William Blair
Downgraded · Outperform → Market Perform · 2014-03-24
—
—
Craig-Hallum
Downgraded · Buy → Hold · 2013-07-30
—
—
Alere Financial
Reiterated · Buy · 2013-07-26
—
—
Janney Capital
Reiterated · Buy · 2013-06-10
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space